It's also authorized for Grownups who are overweight with a number of bodyweight-related disorders, which include substantial blood pressure level or Sort 2 diabetes (higher blood sugar). In March of 2024, the FDA authorised a further indication for Wegovy—to lessen the chance of cardiovascular death, coronary heart assault, and stroke https://glp-1weightlossmed.com/product/wegovy/